{
    "title": "Novo Nordisk raises full-year guidance again as US sales of Wegovy, Ozempic fly",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12628047/UPDATE-2-Novo-Nordisk-raises-year-guidance-U-S-sales-Wegovy-Ozempic-fly.html",
    "date": "2023-10-13",
    "keywords": [
        "year",
        "wegovy",
        "outlook",
        "growth",
        "operating",
        "profit",
        "company",
        "demand",
        "ozempic",
        "august",
        "quarter",
        "reporting",
        "copenhagen",
        "nordisk",
        "friday",
        "time",
        "drug",
        "medication",
        "recordhigh",
        "news",
        "gmt",
        "drugmaker",
        "forecast",
        "interest",
        "tax",
        "ebit",
        "range",
        "novo",
        "injection",
        "version",
        "novos",
        "guidance",
        "thirdquarter",
        "surprise",
        "prescription",
        "companys",
        "supply",
        "april",
        "january",
        "louise",
        "breusch",
        "rasmussen",
        "jacob",
        "maggie",
        "fick",
        "editing",
        "terje",
        "solsvik",
        "fenton",
        "sitholematarise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}